|
|
Volumn 375, Issue 9714, 2010, Pages 551-552
|
|
Liraglutide for weight loss in obese people
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLUCAGON LIKE PEPTIDE 1;
INSULIN;
LIRAGLUTIDE;
TETRAHYDROLIPSTATIN;
ANTIOBESITY AGENT;
DRUG DERIVATIVE;
INCRETIN;
DRUG MECHANISM;
DRUG POTENCY;
HUMAN;
IMPAIRED GLUCOSE TOLERANCE;
INSULIN RESISTANCE;
LETTER;
METABOLIC DISORDER;
OBESITY;
PRIORITY JOURNAL;
PROTEIN SECRETION;
WEIGHT REDUCTION;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
FEMALE;
MALE;
NAUSEA;
NOTE;
TREATMENT OUTCOME;
VOMITING;
COMORBIDITY;
METABOLIC SYNDROME X;
ANTI-OBESITY AGENTS;
FEMALE;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
INCRETINS;
MALE;
NAUSEA;
OBESITY;
TREATMENT OUTCOME;
VOMITING;
WEIGHT LOSS;
COMORBIDITY;
METABOLIC SYNDROME X;
|
|
EID: 76249104609
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)60226-7 Document Type: Letter |
|
Times cited : (6)
|
|
References (5)
|
